Evaluation of Ocular Surface Tumors Using Anterior Segment Optical Coherence Tomography (OCT)

Launched by ASSIUT UNIVERSITY · Jan 29, 2025

Keywords

ClinConnect Summary

This clinical trial is studying a special imaging technique called Anterior Segment Optical Coherence Tomography (AS-OCT) to better understand ocular surface tumors, which are growths on the eye's surface. The goal is to see how AS-OCT can help doctors identify whether these tumors are benign (non-cancerous) or malignant (cancerous) by providing detailed images of the eye's structures. This is especially important because certain tumors, like squamous cell carcinoma, can behave differently and require precise diagnosis for proper treatment.

If you or someone you know has an eye lesion that doctors suspect might be a tumor, you may be eligible to participate in this study. Participants will include individuals aged 65 to 74 who have an eye lesion that could be cancerous. However, those whose lesions have already been confirmed as non-cancerous by tests will not be included. During the trial, participants can expect to undergo a non-invasive imaging procedure that will safely capture high-resolution images of their eye, helping doctors make better decisions about diagnosis and treatment options. The trial is not yet recruiting, so there will be more information to come about how to get involved.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • all patients presented with ocular surface lesion suspected to be neoplastic
• Exclusion Criteria:
• • all patients presented with ocular surface lesion proved by pathology not to be neoplastic